Skip to main content

Mallory Hackett

By Mallory Hackett | 12:26 pm | May 06, 2021
Eli Lilly’s Tempo Pen and connected Tempo Smart Button will integrate with the software platforms and/or medical devices offered by the diabetes management companies.
By Mallory Hackett | 03:21 pm | May 05, 2021
 The round was led by the Chernin Group and Elysian Park.   
By Mallory Hackett | 12:50 pm | May 05, 2021
The Boost Mobile and K Health partnership gives the wireless provider’s customers and their families access to a variety of telehealth options.   
By Mallory Hackett | 11:41 am | May 05, 2021
General Atlantic, Centene and AXA Venture Partners led the Series D round.
By Mallory Hackett | 03:50 pm | May 04, 2021
 This latest infusion of cash values Collective Health at $1.5 billion.   
By Mallory Hackett | 01:09 pm | May 04, 2021
Coming in six months after its $26 million Series A round, Headway now boasts $103 million in total funding and a new valuation of $750 million.   
By Mallory Hackett | 11:35 am | May 04, 2021
When a person’s vascular age is determined to be significantly older than their chronological age, it can be an indicator of possible cardiovascular health issues.   
By Mallory Hackett | 03:33 pm | May 03, 2021
Alife also added Deena Shakir, a partner at Lux Capital, to its board of directors.   
By Mallory Hackett | 12:48 pm | May 03, 2021
MindMaze creates gamified digital neurotherapeutics for patients with neurological injuries and conditions such as stroke, traumatic brain injury, multiple sclerosis or Parkinson’s disease.
By Mallory Hackett | 03:32 pm | April 30, 2021
As of Friday afternoon, Dexcom’s stock has fallen 6.3% from about $422 to $395.